The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / How to Diagnose Antisynthetase Syndrome

How to Diagnose Antisynthetase Syndrome

March 17, 2017 • By Quretul Quresh, MD, & Stephen Lindsey, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
figure 1

Figure 1.
This computed tomography of the chest shows bilateral, diffuse, ground-glass opacities and nodular opacities with intralobular septal thickening.

Antisynthetase syndrome (AS) is strongly associated with the presence of antibodies to aminoacyl-transfer RNA (tRNA) synthetases (ARSs) that are implicated in the pathogenesis of myositis and interstitial lung disease (ILD).

You Might Also Like
  • Fellow’s Forum Case Report: Diagnosing Antisynthetase Syndrome
  • Autoantibodies in Autoimmune Myopathy
  • How to Recognize, Diagnose Periodic Fever Syndromes in Adults
Explore This Issue
March 2017

Antibodies against eight antisynthetases have been identified and are detected in 16–26% of patients with idiopathic inflammatory myopathies (IIM).1 Serum assays for five of these antibodies are commercially available: anti-histidyl (Jo-1), anti-threonyl (PL-7), anti-alanyl (PL-12), anti-isoleucyl (OJ) and anti-glycl (EJ). Anti-Jo-1 antibodies are seen more commonly in patients with polymyositis and dermatomyositis compared with the others that are found less frequently.2 These antibodies usually target the enzymatic component of tRNA synthetases; only anti-PL-12 recognizes tRNA directly.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Few articles in the literature describe the outcome of patients with anti-PL-12 AS. We present a case of anti-PL-12 AS, along with discussion of the outcome, functional course, complications and mortality in AS patients presenting with this rare antibody, along with a brief review of myositis-related antibodies.

Case

In early 2009, a 49-year-old Caucasian male presented to the outpatient rheumatology clinic with complaints of progressive shortness of breath. He had a history of undifferentiated connective tissue disease, sclerodactyly and Raynaud’s symptoms. A review of systems was positive for diffuse joint pains, intermittent fevers, hyperkeratotic skin lesions of both hands, esophageal dysmotility and decreased motility in his gut. His medical history was also significant for splenic vein thrombosis and deep venous thrombosis, for which he was on chronic anticoagulation.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The physical examination revealed decreased bilateral breath sounds, puffy fingers, hyperkeratotic skin over the palmar surface of both hands, no clinical evidence of synovitis and normal muscle strength.

Laboratory analysis revealed mild inflammation with C-reactive protein (CRP) of 15 mg/L, normal creatine phosphokinase (CPK) and normal liver function tests. Antinuclear antibodies (ANA) were negative, and no anti-cytoplasmic staining was detected on indirect immunofluorescence. Rheumatoid factor and anticyclic citrullinated protein antibodies were negative.

An additional workup showed negative anti-neutrophil cytoplasmic antibodies, negative anti-SSA antibodies, and negative PM-Scl antibodies. Pulmonary function tests revealed mild restrictive ventilator defect with severe reduction in diffusion capacity and forced vital capacity (FVC). Forced expiratory volume in 1 second (FEV 1) was 75%, and carbon monoxide diffusion capacity (DLCO) was 36%. High-resolution computed tomography (CT) of the chest demonstrated bilateral pulmonary infiltrates with alveolitis.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The patient was monitored regularly with clinical, laboratory, radiological and lung function evaluations for four years. He developed progression of ILD with declining pulmonary function tests. High-resolution CT imaging showed bilateral pulmonary infiltrates and alveolitis with diffuse, bilateral, ground-glass opacities and nodular infiltrates with intraseptal wall thickening compatible with nonspecific interstitial pneumonia (see Figure 1).

Pages: 1 2 3 4 5 | Single Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: aminoacyl-transfer RNA, Antisynthetase Syndrome, Clinical, Diagnosis, inflammatory, Interstitial Lung Disease, Myopathies, myositis, outcome, patient care, Research, rheumatologist, rheumatology, syndrome, TreatmentIssue: March 2017

You Might Also Like:
  • Fellow’s Forum Case Report: Diagnosing Antisynthetase Syndrome
  • Autoantibodies in Autoimmune Myopathy
  • How to Recognize, Diagnose Periodic Fever Syndromes in Adults
  • Inflammatory Myopathies Difficult to Diagnose, Treat

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)